Ascletis Pharma Inc. 1672.HK
1672.HK
Ascletis Pharma Inc. 0775.HK
CK Life Sciences Int'l., (Holdings) Inc. 2616.HK
CStone Pharmaceuticals 2171.HK
CARsgen Therapeutics Holdings Limited 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 2142.HK
HBM Holdings Limited 2509.HK
Qyuns Therapeutics Co., Ltd. 2256.HK
Abbisko Cayman Limited 1477.HK
Ocumension Therapeutics 2192.HK
Medlive Technology Co., Ltd.
Ascletis Pharma Inc. 0775.HK
CK Life Sciences Int'l., (Holdings) Inc. 2616.HK
CStone Pharmaceuticals 2171.HK
CARsgen Therapeutics Holdings Limited 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 2142.HK
HBM Holdings Limited 2509.HK
Qyuns Therapeutics Co., Ltd. 2256.HK
Abbisko Cayman Limited 1477.HK
Ocumension Therapeutics 2192.HK
Medlive Technology Co., Ltd.
Performance
| Periode | 1672.HK | 0775.HK | 2616.HK | 2171.HK | 2315.HK | 2142.HK | 2509.HK | 2256.HK | 1477.HK | 2192.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 87.25 % | 18.42 % | 172.51 % | 34.77 % | 101.53 % | 78.27 % | 228.22 % | 128.51 % | 60.59 % | 0.96 % |
| YTD | 185.49 % | 119.51 % | 179.18 % | 83.05 % | 186.51 % | 546.46 % | 322.60 % | 254.42 % | 67.98 % | 19.57 % |
| 1Y | 585.19 % | 87.50 % | 280.00 % | 328.18 % | 217.49 % | 907.87 % | 97.72 % | 302.84 % | 24.96 % | 31.63 % |
| 3Y | 302.17 % | 45.16 % | 91.60 % | 29.49 % | -8.54 % | 932.26 % | 20.57 % | 435.27 % | -19.71 % | 69.49 % |
| 5Y | 203.28 % | 2.27 % | -43.93 % | -42.77 % | -8.54 % | 16.15 % | 20.57 % | 26.05 % | -66.33 % | -62.55 % |
| 10Y | -33.93 % | 21.62 % | -46.81 % | -42.77 % | -8.54 % | 16.15 % | 20.57 % | 26.05 % | -79.30 % | -62.55 % |
| Depuis le début | -33.93 % | -69.05 % | -46.81 % | -42.77 % | -8.54 % | 16.15 % | 20.57 % | 26.05 % | -79.30 % | -62.55 % |